Primary cutaneous B-cell lymphomas;Primäre kutane B-zell-lymphome

JDDG - Journal of the German Society of Dermatology

Volumn 2, Issue 7, 2004, Pages 605-621

  Kerl, Helmut ^a,b   Cerroni, Lorenzo ^a   Fink Puches, Regina ^a   Wolf, Ingrid H ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Universitatsklinik fur Dermatologie und Venerologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; BORRELIA BURGDORFERI; CANCER CLASSIFICATION; CUTANEOUS MARGINAL ZONE LYMPHOMA; DIFFUSE LARGE B CELL LYMPHOMA; EXTRANODAL MARGINAL ZONE B CELL LYMPHOMA; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOLOGY; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MOLECULAR BIOLOGY; PLASMACYTOMA; PRECURSOR B LYMPHOBLASTIC LYMPHOMA; PRIMARY CUTANEOUS B CELL LYMPHOMA; REVIEW; SERODIAGNOSIS; SKIN ASSOCIATED LYMPHOID TISSUE; SKIN LYMPHOMA; SKIN PLASMACYTOMA;

EID: 3142703590     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2004.04507.x     Document Type: Review

References (48)

1. Kerl H, Kodama K, Cerroni L. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas. J Derm Sci (2004, im Druck).
2. Cerroni L, Kerl H, Gatter K. An illustrated guide to skin lymphoma. Blackwell Science, Oxford (2004).
3. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC Press, Lyon, 2001.
4. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJLM. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371.
5. Fink-Puches R, Zenahlik P, Bäck B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on dinicopathologic features observed in a large group of patients. Blood 2002; 99: 800-805.
6. Cerroni L, Zöchling N, Pütz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457-461.
7. Goodlad JR, Davidson MM, Hollowood K, Ling C, MacKenzie C, Christie I, Batstone PJ, Ho-Yen DO. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland. Am J Surg Pathol 2000; 24: 1279-1285.
8. Kerl H, Rauch H-J, Hödl St. Cutaneous B cell lymphomas. In: Goos M, Christophers E: Lymphoproliferative diseases of the skin. Berlin: Springer, 1982: 179-191.
9. Kerl H, Cerroni L. Primary B-cell lymphomas of the skin. Ann Oncol 1997; 8 (Suppl 2): S29-S32.
10. Mason D et al. Leucocyte typing VII. White cell differentiation antigens. Proceedings of the Seventh International Workshop and Conference held in Harrogate, United. Kingdom. University Press, Oxford, 2002.
11. Gellrich S. Erforschung der Ätiopathogenese primary kutaner Lymphome mit Hilfe der Mikromanipulation und Einzelzell-PCR. Habilitationsschrift, Humboldt-Universität, Berlin, 2003.
12. Cerroni L, Arzberger E, Pütz B, Höfler G, Metze D, Sander CA, Rose C, Wolf P, Rütten A, McNiff JM, Kerl H. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000; 95: 3922-3928.
13. Gellrich S, Rutz S, Golembowski S, Jacobs C, von Zimmermann M, Lorenz P, Audring H, Muche M, Sterry W, Jahn S. Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis. J Invest Dermatol 2001; 117: 1512-1520.
14. Liebler DC. Introduction to proteomics. Tools for the new biology. Humana Press, Totowa, NJ, USA, 2002.
15. Ladanyi M, Gerald WL. Expression profiling of human tumors. Diagnostic and research applications. Humana Press, Totowa, NJ, USA, 2003.
16. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003; 348: 1777-1785.
17. Storz M, van de Rijn M, Kim YH, Mraz-Gernhard S, Hoppe RT, Kohler S. Gene expression profiles of cutaneous B cell lymphoma. J Invest Dermatol 2003; 120: 865-870.
18. Cook JR, Sherer M, Craig FE, Shekhter-Levin S, Swerdlow SH. T(14;18)(q32;q21) involving MALT1 and IgH genes in an extranodal diffuse large B-cell lymphoma. Hum Pathol 2003; 34: 1212-1215.
19. Cerroni L, Signoretti S, Höfler G, Annessi G, Pütz B, Lackinger E, Metze D, Giannetti A, Kerl H. Primary cutaneous marginal zone B-cell lymphoma: A recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997; 21: 1307-1315.
20. de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM. Cutaneous B-cell lymphomas of follicular and marginal zone types. Use of Bd-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol 2001; 25: 732-741.
21. Servitje O, Gallardo F, Estrach T, Pujol RM, Blanco A, Fernández-Sevilla A, Pétriz L, Peyri J, Romagosa V. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 2002; 147: 1147-1158.
22. Pimpinelli N, Santucci M, Giannotti B. Cutaneous lymphoma: A clinically relevant classification. Int J Dermatol 1993; 32: 695-700.
23. Falini B, Tiaccil E, Hatzivassiliou G, Kurth J, Kuppers R, Cattoretti G, Dalla-Favera R. IRTA1: A new molecule associated with normal and neoplastic marginal zone B cells. J Clin Pathol 2002; 55 (Suppl 1): A31 (Abstr).
24. Streubel B, Laprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, Raderer M, Chott A. T(14;18)(q32;q21) involving IgH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335-2339.
25. Kerl H, Kresbach H. Germinal center cell-derived lymphomas of the skin. J Dermatol Surg Oncol 1984; 10: 291-295.
26. Cerroni L, Kerl H. Primary cutaneous follicle center cell lymphoma. Leukemia and Lymphoma 2001; 42: 891-900.
27. Franco R, Fernández-Vázquez A, Mollejo M, Cruz MA, Camacho FI, Garcia JF, Nararrete M, Piris MA. Cutaneous presentation of follicular lymphomas. Mod Pathol 2001; 14: 913-919.
28. Aguilera NSI, Tomaszewski M-M, Moad JC, Bauer FA, Taubenberger JK, Abbondanzo SL. Cutaneous follicle center lymphoma: A clinicopathologic study of 19 cases. Mod Pathol 2001; 14: 828-835.
29. Goodlad JR, Krajewski AS, Batstone PJ, McKay P, White JM, Benton EC, Kavanagh GM, Lucraft HH (Scotland and Newcastle Lymphoma Group). Primary cutaneous follicular lymphoma. A clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol 2002; 26: 733-741.
30. Hoefnagel JJ, Vermeer MH, Jansen PM, Fleuren GJ, Meijer CJLM, Willemze R. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol 2003; 149: 1183-1191.
31. Cerroni L, Volkenandt M, Rieger E, Soyer HP, Kerl H. Bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994; 102: 231-235.
32. Volkenandt M, Cerroni L, Rieger E, Soyer HP, Koch O, Wienecke R, Atzpodien J, Bertino JR, Kerl H. Analysis of the 14; 18 translocation in cutaneous lymphomas using the polymerase chain reaction. J Cutan Pathol 1992; 19: 353-356.
33. Grange F, Bekkenk MW, Wechsler J, Meijer CJLM, Cerroni L, Bernengo M, Bosq J, Hedelin G, Fink-Puches R, van Vloten WA, Joly P, Bagot M, Willemze R. Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study. J Clin Oncol 2001; 19: 3602-3610.
34. Paulli M, Viglio A, Vivenza D, Capello D, Rossi D, Riboni R, Lucioni M, Incardona P, Boveri E, Bellosta M, Orlandi E, Borroni G, Lazzarino M, Berti E, Alessi E, Magrini U, Gaidano G. Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entity. Hum Pathol 2002; 33: 937-943.
35. Grange F, Petrella T, Beylot-Barry M, Joly P, D'Incan M, Vergier B, Esteve E, Machet L, Avril MF, Bernard P, Bagot M, Wechsler J. L'expression de la protéine bcl-2 est le meilleur facteur pronostique au cours des lymphomes B cutanés primitifs à grandes cellules. Ann Dermatol Venereol 2003; 130: 4S35-4S36.
36. Vermeer M, Dijkman R, Hoefnagel JJ, Willemze R, Tensen CP. Identification of gene expression profiles that segregate patients with distinct primary cutaneous large B cell lymphoma. J Invest Dermatol 2003; 121: 158 (Abstr).
37. Kerl H, Fink-Puches R, Wolf IH, Cerroni L. Management of patients with primary cutaneous B-cell lymphomas. Actas Dermatol Dermatopatol 2002; 2: 51-53.
38. Dummer R, Kempf W, Hess-Schmid M, Häffner A, Burg G. Therapy of cutaneous lymphoma - Current practice and future developments. Onkologie 2003; 26: 366-372.
39. Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio J-A, Zhuang H, Pitsilos S, Bagg A, Downs L, Mehrotra A, Kim S, Alavi A, Schuster SJ. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101: 3875-3876.
40. Zenahlik P, Fink-Puches R, Kapp KS, Kerl H, Cerroni L. Die Therapie der primären kutanen B-Zell-Lymphome. Hautarzt 2000; 51: 19-24.
41. Piccinno R, Caccialanza M, Berti E. Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma. Eur J Dermatol 2003; 13: 49-52.
42. Paul T, Radny P, Kröber SM, Paul A, Blaheta H-J, Garbe C. Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol 2001; 144: 1239-1243.
43. Gellrich S, Muche JM, Pelzer K, Audring H, Sterry W. Der Anti-CD20-Antikörper bei primary kutanen B-Zell-Lymphomen. Erste Erfahrungen in der dermatologischen Anwendung. Hautarzt 2001; 52: 205-210.
44. Schmook T, Stockfleth E, Lischner St, Gahn B, Christophers E, Hauschild A. Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP). Clin Experiment Dermatol 2003; 28: 31-33.
45. Imai Y, Isoda K-I, Ito E, Hakamada A, Yamanishi K, Mizutani H. Primary cutaneous follicle center cell lymphoma of the scalp successfully treated with anti CD20 monoclonal antibody and CHOP combination therapy with no subsequent permanent loss of hair. J Dermatol 2003; 30: 683-688.
46. Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E, Borisch B, Piffaretti J-C, Cavalli F, Isaacson PG. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000; 31: 263-268.
47. Hofbauer GFL, Kessler B, Kempf W, Nestle FO, Burg G, Dummer R. Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology 2001; 203: 168-170.
48. Coiffier B, Lepage E, Brière J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, van den Neste E, Salles G, Gaulard P, Reyes F, Gisselrecht C. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.